SOP for IDE-Specific Safety Reporting and Device Deviations (21 CFR 812)

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-ide-specific-safety-reporting-and-device-deviations-21-cfr-812”
},
“headline”: “SOP for IDE-Specific Safety Reporting and Device Deviations (21 CFR 812)”,
“description”: “This SOP defines procedures for IDE-specific safety reporting and device deviation management under 21 CFR 812. It ensures timely reporting of unanticipated adverse device effects (UADEs), device malfunctions, and compliance with FDA requirements for investigational device studies.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Published on 21/12/2025

Standard Operating Procedure for IDE-Specific Safety Reporting and Device Deviations (21 CFR 812)

SOP No.	CR/OPS/134/2025
Supersedes	NA
Page No.	1 of 74
Issue Date	26/08/2025
Effective Date	01/09/2025
Review Date	01/09/2026

Table of Contents

Purpose

The purpose of this SOP is to define procedures for safety reporting

and management of device deviations in clinical trials regulated under the U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) regulations (21 CFR 812). It ensures that unanticipated adverse device effects (UADEs), device malfunctions, and deviations are reported and managed in compliance with regulatory timelines.

Scope

This SOP applies to sponsors, investigators, CROs, QA personnel, and regulatory affairs staff involved in IDE-regulated clinical investigations. It covers unanticipated adverse device effects, device malfunctions, deviations, IRB notifications, sponsor reports to FDA, and inspection readiness.

Responsibilities

Sponsor: Submits UADE reports to FDA and IRB within required timelines and maintains deviation logs.
Investigator: Reports all device-related SAEs and deviations to sponsor immediately.
CRO: Assists in monitoring, reconciliation, and reporting activities.
Regulatory Affairs: Prepares FDA submissions and maintains inspection readiness.
QA: Audits safety reporting and device deviation records.

Accountability

The Sponsor’s Device Safety Officer is accountable for ensuring compliance with IDE safety reporting and deviation requirements. Investigators are accountable for site-level reporting accuracy.

Procedure

1. Identification of Device-Related Events
1.1 Investigators must report UADEs and device malfunctions to the sponsor within 24 hours.
1.2 Record in Device Event Log (Annexure-1).

2. Sponsor Evaluation
2.1 Assess severity, causality, and expectedness.
2.2 Document in Device Event Assessment Log (Annexure-2).

3. FDA and IRB Reporting
3.1 Submit UADE reports to FDA and all reviewing IRBs within 10 working days.
3.2 Record in UADE Reporting Log (Annexure-3).

4. Device Deviation Management
4.1 Document deviations from protocol or device instructions in Device Deviation Log (Annexure-4).
4.2 Investigate root causes and apply corrective actions.

5. Corrective and Preventive Actions (CAPA)
5.1 Develop CAPA for recurrent deviations.
5.2 Record in CAPA Log (Annexure-5).

6. Safety Database Management
6.1 Maintain validated device safety database with audit trails.
6.2 Perform quarterly reconciliation with clinical data.
6.3 Record in Database Reconciliation Log (Annexure-6).

7. Inspection Readiness
7.1 Maintain UADE and deviation records for FDA inspections.
7.2 Conduct mock inspections documented in Inspection Readiness Log (Annexure-7).

Abbreviations

SOP: Standard Operating Procedure
IDE: Investigational Device Exemption
UADE: Unanticipated Adverse Device Effect
FDA: Food and Drug Administration
IRB: Institutional Review Board
CRO: Contract Research Organization
QA: Quality Assurance
CAPA: Corrective and Preventive Action
TMF: Trial Master File
ISF: Investigator Site File

Documents

Device Event Log (Annexure-1)
Device Event Assessment Log (Annexure-2)
UADE Reporting Log (Annexure-3)
Device Deviation Log (Annexure-4)
CAPA Log (Annexure-5)
Database Reconciliation Log (Annexure-6)
Inspection Readiness Log (Annexure-7)

References

Version: 1.0

Approval Section

Prepared By	Ravi Kumar, Device Safety Specialist
Checked By	Sunita Reddy, QA Officer
Approved By	Dr. Anil Sharma, Head Clinical Operations

Annexures

Annexure-1: Device Event Log

Date	Subject ID	Event	Investigator	Status
01/09/2025	D101	Device Malfunction	PI	Reported

Annexure-2: Device Event Assessment Log

Date	Event	Assessment	Reviewed By	Status
02/09/2025	Device Malfunction	UADE – Related	Sponsor Safety Officer	Confirmed

Annexure-3: UADE Reporting Log

Date	Event	Reported To	Submitted By	Status
03/09/2025	Device Malfunction	FDA/IRB	Reg Affairs	Filed

Annexure-4: Device Deviation Log

Date	Protocol ID	Deviation	Investigator	Status
04/09/2025	IDE-2025-01	Improper Calibration	PI	Corrected

Annexure-5: CAPA Log

Date	Issue	CAPA	Responsible	Status
05/09/2025	Calibration Error	Revised SOP + Training	QA	Implemented

Annexure-6: Database Reconciliation Log

Date	Database	Reconciliation	Reviewed By	Status
10/09/2025	Clinical vs Device Safety DB	Completed	QA	Matched

Annexure-7: Inspection Readiness Log

Date	Agency	Simulation	Performed By	Status
12/09/2025	FDA	Mock Inspection	QA Team	Completed

Revision History

Revision Date	Revision No.	Revision Details	Reason for Revision	Approved By
26/08/2025	00	Initial version	New SOP creation	Head Clinical Operations

For more SOPs visit: Pharma SOP